http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 Jul 2026 08:43:09 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Press+Releases/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html <p align="justify">PHILADELPHIA , July 21, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>ERASCA, INC. (NASDAQ: ERAS):</u></strong></p> <p align="justify">Grabar Law Office is investigating whether certain officers and directors of Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") breached their fiduciary duties owed to the Company and its shareholders.</p> <p align="justify"><strong>What is This Investigation About? </strong>The investigation concerns whether Erasca's directors and senior executives maintained appropriate oversight, disclosure controls, compliance procedures, and risk-management systems relating to the Company's public statements concerning ERAS-0015, a pan-RAS molecular glue candidate being developed for the treatment of RAS-mutant solid tumors.</p> <p http://www.streetinsider.com/Globe+Newswire/Notice+to+Long-Term+Shareholders+of+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+Insulet+Corporation+%28NASDAQ%3A+PODD%29%3B+Photronics%2C+Inc.+%28NASDAQ%3A+PLAB%29%3B+and+Via+Transportation%2C+Inc.+%28NYSE%3A+VIA%29%3A+Grabar+Law+Office+is+Inv/26792935.html Tue, 21 Jul 2026 08:43:09 -0400 ERAS ERAS ERAS ERAS PLAB PLAB PLAB PLAB PLAB PODD PODD PODD PODD PODD VIA VIA VIA VIA VIA